Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

Enanta has always been well funded as a research boutique. But to go it alone on some of these products would require a massive investment in personnel in regulatory, manufacturing, commercial, supply chain, etc. and I never had a strong feeling that they were committed to that....

I am just playing a hunch as to why Enanta may be able to change strategic direction more easily with respect to their business as a whole.

I still don't understand you reasoning. While it indeed will take a massive amount of resources, positive data from any of these programs, HSV, HepB, NASH or Covid fronts will jack up the stock price and make it easier to raise massive amounts of cash if ENTAS tires to go it alone. Of course, ENTA will be in the catbird seat to make a deal with a company which does have massive resources and experience. However, ENTA will be able to negotiate from a position of strength unlike what happened with Hep-C and ABBV. I expect a partnership on favorable terms for ENTA or a buyout as some time. I prefer a partnership but what I prefer doesn't matter.